{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:28:30Z","timestamp":1788629310979,"version":"build-2803163510"},"reference-count":41,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rett syndrome (RTT) is a neurodevelopmental disorder that primarily affects females. Recent work indicates the potential for disease modifying therapies. However, there remains a need to develop outcome measures for use in clinical trials. Using data from a natural history study (n = 1,075), we examined the factor structure, internal consistency, and validity of the clinician-reported Motor Behavior Assessment scale (MBA). The analysis resulted in a five-factor model: (1) motor dysfunction, (2) functional skills, (3) social skills, (4) aberrant behavior, and (5) respiratory behaviors. Item Response Theory (IRT) analyses demonstrated that all items had acceptable discrimination. The revised MBA subscales showed a positive relationship with parent reported items, age, and a commonly used measure of clinical severity in RTT, and mutation type. Further work is needed to evaluate this measure longitudinally and to add items related to the RTT phenotype.<\/jats:p>","DOI":"10.1352\/1944-7558-125.6.493","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T14:16:06Z","timestamp":1605795366000},"page":"493-509","source":"Crossref","is-referenced-by-count":40,"title":["A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials"],"prefix":"10.1080","volume":"125","author":[{"given":"Melissa","family":"Raspa","sequence":"first","affiliation":[{"name":"Melissa Raspa, Carla M. Bann, and Angela Gwaltney, RTI International"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M.","family":"Bann","sequence":"additional","affiliation":[{"name":"Melissa Raspa, Carla M. Bann, and Angela Gwaltney, RTI International"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gwaltney","sequence":"additional","affiliation":[{"name":"Melissa Raspa, Carla M. Bann, and Angela Gwaltney, RTI International"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Benke","sequence":"additional","affiliation":[{"name":"Timothy A. Benke, University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Fu","sequence":"additional","affiliation":[{"name":"Cary Fu, Vanderbilt Kennedy Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Glaze","sequence":"additional","affiliation":[{"name":"Daniel G. Glaze, Baylor College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Haas","sequence":"additional","affiliation":[{"name":"Richard Haas, University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heydemann","sequence":"additional","affiliation":[{"name":"Peter Heydemann, Rush University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Jones","sequence":"additional","affiliation":[{"name":"Mary Jones, Benioff Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Walter E. Kaufmann, Greenwood Genetic Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lieberman","sequence":"additional","affiliation":[{"name":"David Lieberman and Eric Marsh, Children's Hospital Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Marsh","sequence":"additional","affiliation":[{"name":"David Lieberman and Eric Marsh, Children's Hospital Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Peters","sequence":"additional","affiliation":[{"name":"Sarika Peters, Vanderbilt Kennedy Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ryther","sequence":"additional","affiliation":[{"name":"Robin Ryther, Washington University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Standridge","sequence":"additional","affiliation":[{"name":"Shannon Standridge, Cincinnati Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Skinner","sequence":"additional","affiliation":[{"name":"Steven A. Skinner, Greenwood Genetic Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Percy","sequence":"additional","affiliation":[{"name":"Alan K. Percy, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Neul","sequence":"additional","affiliation":[{"name":"Jeffrey L. Neul, Vanderbilt Kennedy Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"2020111911300275500_i1944-7558-125-6-493-AhonniskaAssa1","doi-asserted-by":"crossref","unstructured":"Ahonniska-Assa,\n              J.,\n            \n            \n              Polack,\n              O.,\n            \n            \n              Saraf,\n              E.,\n            \n            \n              Wine,\n              J.,\n            \n            \n              Silberg,\n              T.,\n            \n            \n              Nissenkorn,\n              A.,\n             &\n\t\t\t\t\t\tBen-Zeev,B.\n          (2018).\n\t\t\t\t\tAssessing cognitive functioning in females with Rett syndrome by eye-tracking methodology.\n\t\t\t\t\tEuropean Journal of Paediatric Neurology,\n\t\t\t\t\t22(1),\n\t\t\t\t\t39\u2013\n\t\t\t\t\t45.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.ejpn.2017.09.010","DOI":"10.1016\/j.ejpn.2017.09.010"},{"key":"2020111911300275500_i1944-7558-125-6-493-Amir1","doi-asserted-by":"crossref","unstructured":"Amir,\n              R. E.,\n            \n            \n              Van den Veyver,\n              I. B.,\n            \n            \n              Wan,\n              M.,\n            \n            \n              Tran,\n              C. Q.,\n            \n            \n              Francke,\n              U.,\n             &\n\t\t\t\t\t\tZoghbi,H. Y.\n          (1999).\n\t\t\t\t\tRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.\n\t\t\t\t\tNature Genetics,\n\t\t\t\t\t23(2),\n\t\t\t\t\t185.\n\t\t\t\t\thttps:\/\/doi.org\/10.1038\/13810","DOI":"10.1038\/13810"},{"key":"2020111911300275500_i1944-7558-125-6-493-Barnes1","doi-asserted-by":"crossref","unstructured":"Barnes,\n              K. V.,\n            \n            \n              Coughlin,\n              F. R.,\n            \n            \n              O'Leary,\n              H. M.,\n            \n            \n              Bruck,\n              N.,\n            \n            \n              Bazin,\n              G. A.,\n            \n            \n              Beinecke,\n              E. B.,\n            \n            \n              Walco,\n              A. C.,\n            \n            \n              Cantwell,\n              N. G.,\n             & &\n\t\t\t\t\t\tKaufmann,W. E.\n          (2015).\n\t\t\t\t\tAnxiety-like behavior in Rett syndrome: Characteristics and assessment by anxiety scales.\n\t\t\t\t\tJournal of Neurodevelopmental Disorders,\n\t\t\t\t\t7(1),\n\t\t\t\t\t30.\n\t\t\t\t\thttps:\/\/doi.org\/10.1186\/s11689-015-9127-4","DOI":"10.1186\/s11689-015-9127-4"},{"key":"2020111911300275500_i1944-7558-125-6-493-Basch1","doi-asserted-by":"crossref","unstructured":"Basch,\n              E.,\n             &\n\t\t\t\t\t\tBennett,A. V.\n          (2014).\n\t\t\t\t\tPatient-reported outcomes in clinical trials of rare diseases.\n\t\t\t\t\tJournal of General Internal Medicine,\n\t\t\t\t\t29(3),\n\t\t\t\t\t801\u2013\n\t\t\t\t\t803.\n\t\t\t\t\thttps:\/\/doi.org\/10.1007\/s11606-014-2892-z","DOI":"10.1007\/s11606-014-2892-z"},{"key":"2020111911300275500_i1944-7558-125-6-493-Benjamin1","doi-asserted-by":"crossref","unstructured":"Benjamin,\n              K.,\n            \n            \n              Vernon,\n              M. K.,\n            \n            \n              Patrick,\n              D. L.,\n            \n            \n              Perfetto,\n              E.,\n            \n            \n              Nestler-Parr,\n              S.,\n             &\n\t\t\t\t\t\tBurke,L.\n          (2017).\n\t\t\t\t\tPatient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: An ISPOR COA emerging good practices task force report.\n\t\t\t\t\tValue in Health,\n\t\t\t\t\t20(7),\n\t\t\t\t\t838\u2013\n\t\t\t\t\t855.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.jval.2017.05.015","DOI":"10.1016\/j.jval.2017.05.015"},{"key":"2020111911300275500_i1944-7558-125-6-493-BerryKravis1","doi-asserted-by":"crossref","unstructured":"Berry-Kravis,\n              E.,\n            \n            \n              Des Portes,\n              V.,\n            \n            \n              Hagerman,\n              R.,\n            \n            \n              Jacquemont,\n              S.,\n            \n            \n              Charles,\n              P.,\n            \n            \n              Visootsak,\n              J.,\n            \n            \n              Brinkman,\n              M.,\n            \n            \n              Rerat,\n              K.,\n            \n            \n              Koumaras,\n              B.,\n            \n            \n              Zhu,\n              L.,\n            \n            \n              Barth,\n              G. M.,\n            \n            \n              Jaecklin,\n              G. A.,\n            \n            \n              von Raison,\n              F.\n            \n          \n          (2016).\n\t\t\t\t\tMavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.\n\t\t\t\t\tScience Translational Medicine,\n\t\t\t\t\t8(321),\n\t\t\t\t\t321ra5.https:\/\/doi.org\/10.1126\/scitranslmed.aab4109","DOI":"10.1126\/scitranslmed.aab4109"},{"key":"2020111911300275500_i1944-7558-125-6-493-BerryKravis2","doi-asserted-by":"crossref","unstructured":"Berry-Kravis,\n              E.,\n            \n            \n              Hessl,\n              D.,\n            \n            \n              Abbeduto,\n              L.,\n            \n            \n              Reiss,\n              A. L.,\n            \n            \n              Beckel-Mitchener,\n              A.,\n            \n            \n              Urv,\n              T. K.\n             ,\n\t\t\t\t\t&\n\t\t\t\t\tthe Outcome Measures Working Group(2013).\n\t\t\t\t\tOutcome measures for clinical trials in fragile X syndrome.\n\t\t\t\t\tJournal of Developmental and Behavioral Pediatrics,\n\t\t\t\t\t34(7),\n\t\t\t\t\t508\u2013\n\t\t\t\t\t522.\n\t\t\t\t\thttps:\/\/doi.org\/10.1097\/DBP.0b013e31829d1f20","DOI":"10.1097\/DBP.0b013e31829d1f20"},{"key":"2020111911300275500_i1944-7558-125-6-493-Cai1","unstructured":"Cai,\n              L.,\n            \n            \n              Thissen,\n              D.,\n             &\n\t\t\t\t\t\tdu Toit,S. H. C.\n          (2011).\n\t\t\t\t\tIRTPRO for Windows [Computer software].\n\t\t\t\t\tScientific Software International."},{"key":"2020111911300275500_i1944-7558-125-6-493-Clarkson1","doi-asserted-by":"crossref","unstructured":"Clarkson,\n              T.,\n            \n            \n              LeBlanc,\n              J.,\n            \n            \n              DeGregorio,\n              G.,\n            \n            \n              Vogel-Farley,\n              V.,\n            \n            \n              Barnes,\n              K.,\n            \n            \n              Kaufmann,\n              W. E.,\n             &\n\t\t\t\t\t\tNelson,C. A.\n          (2017).\n\t\t\t\t\tAdapting the Mullen Scales of Early Learning for a standardized measure of development in children with Rett syndrome.\n\t\t\t\t\tIntellectual and Developmental Disabilities,\n\t\t\t\t\t55(6),\n\t\t\t\t\t419\u2013\n\t\t\t\t\t431.\n\t\t\t\t\thttps:\/\/doi.org\/10.1352\/1934-9556-55.6.419","DOI":"10.1352\/1934-9556-55.6.419"},{"key":"2020111911300275500_i1944-7558-125-6-493-Downs1","doi-asserted-by":"crossref","unstructured":"Downs,\n              J.,\n            \n            \n              Leonard,\n              H.,\n            \n            \n              Jacoby,\n              P.,\n            \n            \n              Brisco,\n              L.,\n            \n            \n              Baikie,\n              G.,\n             &\n\t\t\t\t\t\tHill,K.\n          (2015).\n\t\t\t\t\tRett syndrome: Establishing a novel outcome measure for walking activity in an era of clinical trials for rare disorders.\n\t\t\t\t\tDisability and Rehabilitation,\n\t\t\t\t\t37(21),\n\t\t\t\t\t1992\u2013\n\t\t\t\t\t1996.\n\t\t\t\t\thttps:\/\/doi.org\/10.3109\/09638288.2014.993436","DOI":"10.3109\/09638288.2014.993436"},{"key":"2020111911300275500_i1944-7558-125-6-493-Djukic1","doi-asserted-by":"crossref","unstructured":"Djukic,\n              A.,\n            \n            \n              Holtzer,\n              R.,\n            \n            \n              Shinnar,\n              S.,\n            \n            \n              Muzumdar,\n              H.,\n            \n            \n              Rose,\n              S. A.,\n            \n            \n              Mowrey,\n              W.,\n            \n            \n              Galanopoulou,\n              A. S.,\n            \n            \n              Shinnar,\n              R.,\n            \n            \n              Jankowski,\n              J. J.,\n            \n            \n              Feldman,\n              J. F.,\n            \n            \n              Pillai,\n              S.,\n             &\n\t\t\t\t\t\tMoshe,S. L.\n          (2016).\n\t\t\t\t\tPharmacologic treatment of Rett syndrome with Glatiramer acetate.\n\t\t\t\t\tPediatric Neurology,\n\t\t\t\t\t61,\n\t\t\t\t\t51\u2013\n\t\t\t\t\t57.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.pediatrneurol.2016.05.010","DOI":"10.1016\/j.pediatrneurol.2016.05.010"},{"key":"2020111911300275500_i1944-7558-125-6-493-FitzGerald1","doi-asserted-by":"crossref","unstructured":"FitzGerald,\n              P. M.,\n            \n            \n              Jankovic,\n              J.,\n             &\n\t\t\t\t\t\tPercy,A. K.\n          (1990).\n\t\t\t\t\tRett syndrome and associated movement disorders.\n\t\t\t\t\tMovement Disorders: Official Journal of the Movement Disorder Society,\n\t\t\t\t\t5(3),\n\t\t\t\t\t195\u2013\n\t\t\t\t\t202.\n\t\t\t\t\thttps:\/\/doi.org\/10.1002\/mds.870050303","DOI":"10.1002\/mds.870050303"},{"key":"2020111911300275500_i1944-7558-125-6-493-Gadalla1","doi-asserted-by":"crossref","unstructured":"Gadalla,\n              K. K.,\n            \n            \n              Bailey,\n              M. E.,\n             &\n\t\t\t\t\t\tCobb,S. R.\n          (2011).\n\t\t\t\t\tMeCP2 and Rett syndrome: Reversibility and potential avenues for therapy.\n\t\t\t\t\tBiochemical Journal,\n\t\t\t\t\t439(1),\n\t\t\t\t\t1\u2013\n\t\t\t\t\t14.\n\t\t\t\t\thttps:\/\/doi.org\/10.1042\/BJ20110648","DOI":"10.1042\/BJ20110648"},{"key":"2020111911300275500_i1944-7558-125-6-493-Glaze1","doi-asserted-by":"crossref","unstructured":"Glaze,\n              D. G.,\n            \n            \n              Neul,\n              J. L.,\n            \n            \n              Kaufmann,\n              W. E.,\n            \n            \n              Berry-Kravis,\n              E.,\n            \n            \n              Condon,\n              S.,\n            \n            \n              Stoms,\n              G.,\n            \n            \n              Oosterholt,\n              S.,\n            \n            \n              Della Pasqua,\n              O.,\n            \n            \n              Glass,\n              L.,\n            \n            \n              Jones,\n              N. E.,\n             &\n\t\t\t\t\t\tPercy,A. K.\n          (2019).\n\t\t\t\t\tDouble-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.\n\t\t\t\t\tNeurology,\n\t\t\t\t\t92(16),\n\t\t\t\t\te1912\u2013\n\t\t\t\t\te1925.\n\t\t\t\t\thttps:\/\/doi.org\/10.1212\/WNL.0000000000007316","DOI":"10.1212\/WNL.0000000000007316"},{"key":"2020111911300275500_i1944-7558-125-6-493-Glaze2","doi-asserted-by":"crossref","unstructured":"Glaze,\n              D. G.,\n            \n            \n              Neul,\n              J. L.,\n            \n            \n              Percy,\n              A.,\n            \n            \n              Feyma,\n              T.,\n            \n            \n              Beisang,\n              A.,\n            \n            \n              Yaroshinsky,\n              A.,\n            \n            \n              Stoms,\n              G.,\n            \n            \n              Zuchero,\n              D.,\n            \n            \n              Horrigan,\n              J.,\n            \n            \n              Glass,\n              L.,\n             &\n\t\t\t\t\t\tJones,N. E.\n          (2017).\n\t\t\t\t\tA double-blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of Rett syndrome.\n\t\t\t\t\tPediatric Neurology,\n\t\t\t\t\t76,\n\t\t\t\t\t37\u2013\n\t\t\t\t\t46.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.07.002","DOI":"10.1016\/j.pediatrneurol.2017.07.002"},{"key":"2020111911300275500_i1944-7558-125-6-493-Gold1","doi-asserted-by":"crossref","unstructured":"Gold,\n              W. A.,\n            \n            \n              Krishnarajy,\n              R.,\n            \n            \n              Ellaway,\n              C.,\n             &\n\t\t\t\t\t\tChristodoulou,J.\n          (2017).\n\t\t\t\t\tRett syndrome: A genetic update and clinical review focusing on comorbidities.\n\t\t\t\t\tACS Chemical Neuroscience,\n\t\t\t\t\t9(2),\n\t\t\t\t\t167\u2013\n\t\t\t\t\t176.\n\t\t\t\t\thttps:\/\/doi.org\/10.1021\/acschemneuro.7b00346","DOI":"10.1021\/acschemneuro.7b00346"},{"key":"2020111911300275500_i1944-7558-125-6-493-Guy1","doi-asserted-by":"crossref","unstructured":"Guy,\n              J.,\n            \n            \n              Gan,\n              J.,\n            \n            \n              Selfridge,\n              J.,\n            \n            \n              Cobb,\n              S.,\n             &\n\t\t\t\t\t\tBird,A.\n          (2007).\n\t\t\t\t\tReversal of neurological defects in a mouse model of Rett syndrome.\n\t\t\t\t\tScience,\n\t\t\t\t\t315(5815),\n\t\t\t\t\t1143\u2013\n\t\t\t\t\t1147.\n\t\t\t\t\thttps:\/\/doi.org\/10.1126\/science.1138389","DOI":"10.1126\/science.1138389"},{"key":"2020111911300275500_i1944-7558-125-6-493-Hagberg1","doi-asserted-by":"crossref","unstructured":"Hagberg,\n              B.,\n            \n            \n              Aicardi,\n              J.,\n            \n            \n              Dias,\n              K.,\n             &\n\t\t\t\t\t\tRamos,O.\n          (1983).\n\t\t\t\t\tA progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases.\n\t\t\t\t\tAnnals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society,\n\t\t\t\t\t14(4),\n\t\t\t\t\t471\u2013\n\t\t\t\t\t479.\n\t\t\t\t\thttps:\/\/doi.org\/10.1002\/ana.410140412","DOI":"10.1002\/ana.410140412"},{"key":"2020111911300275500_i1944-7558-125-6-493-IRDiRC1","unstructured":"International Rare Diseases Consortium (IRDiRC).\n          \n            Patient-centered outcome measures initiatives in the field of rare diseases\n          .\n\t\t\t\t\tFebruary2016.\n\t\t\t\t\thttp:\/\/www.irdirc.org\/wp-content\/uploads\/2017\/12\/PCOM_Post-Workshop_Report_Final.pdf."},{"key":"2020111911300275500_i1944-7558-125-6-493-Jeste1","doi-asserted-by":"crossref","unstructured":"Jeste,\n              S. S.,\n             &\n\t\t\t\t\t\tGeschwind,D. H.\n          (2016).\n\t\t\t\t\tClinical trials for neurodevelopmental disorders: At a therapeutic frontier.\n\t\t\t\t\tScience Translational Medicine,\n\t\t\t\t\t8(321),\n\t\t\t\t\t321fs1.https:\/\/doi.org\/10.1126\/scitranslmed.aad9874","DOI":"10.1126\/scitranslmed.aad9874"},{"key":"2020111911300275500_i1944-7558-125-6-493-Katz1","doi-asserted-by":"crossref","unstructured":"Katz,\n              D. M.,\n            \n            \n              Bird,\n              A.,\n            \n            \n              Coenraads,\n              M.,\n            \n            \n              Gray,\n              S. J.,\n            \n            \n              Menon,\n              D. U.,\n            \n            \n              Philpot,\n              B. D.,\n             &\n\t\t\t\t\t\tTarquinio,D. C.\n          (2016).\n\t\t\t\t\tRett syndrome: Crossing the threshold to clinical translation.\n\t\t\t\t\tTrends in Neurosciences,\n\t\t\t\t\t39(2),\n\t\t\t\t\t100\u2013\n\t\t\t\t\t113.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.tins.2015.12.008","DOI":"10.1016\/j.tins.2015.12.008"},{"key":"2020111911300275500_i1944-7558-125-6-493-Lane1","doi-asserted-by":"crossref","unstructured":"Lane,\n              J. B.,\n            \n            \n              Lee,\n              H. S.,\n            \n            \n              Smith,\n              L. W.,\n            \n            \n              Cheng,\n              P.,\n            \n            \n              Percy,\n              A. K.,\n            \n            \n              Glaze,\n              D. G.,\n            \n            \n              Neul,\n              K. J.,\n            \n            \n              Motil,\n              J. O.,\n            \n            \n              Barrish,\n              S. A.,\n            \n            \n              Skinner,\n              F.,\n            \n            \n              Annese,\n              F.,\n            \n            \n              McNair,\n              L.,\n            \n            \n              Graham,\n              J.,\n            \n            \n              Khwaja,\n              O.,\n            \n            \n              Barnes,\n              K.,\n             &\n\t\t\t\t\t\tKrischer,J. P.\n          (2011).\n\t\t\t\t\tClinical severity and quality of life in children and adolescents with Rett syndrome.\n\t\t\t\t\tNeurology,\n\t\t\t\t\t77(20),\n\t\t\t\t\t1812\u2013\n\t\t\t\t\t1818.\n\t\t\t\t\thttps:\/\/doi.org\/10.1212\/WNL.0b013e3182377dd2","DOI":"10.1212\/WNL.0b013e3182377dd2"},{"key":"2020111911300275500_i1944-7558-125-6-493-Leonard1","doi-asserted-by":"crossref","unstructured":"Leonard,\n              H.,\n            \n            \n              Cobb,\n              S.,\n             &\n\t\t\t\t\t\tDowns,J.\n          (2017).\n\t\t\t\t\tClinical and biological progress over 50 years in Rett syndrome.\n\t\t\t\t\tNature Reviews Neurology,\n\t\t\t\t\t13(1),\n\t\t\t\t\t37.\n\t\t\t\t\thttps:\/\/doi.org\/10.1038\/nrneurol.2016.186","DOI":"10.1038\/nrneurol.2016.186"},{"key":"2020111911300275500_i1944-7558-125-6-493-Moretti1","doi-asserted-by":"crossref","unstructured":"Moretti,\n              P.,\n             &\n\t\t\t\t\t\tZoghbi,H. Y.\n          (2006).\n\t\t\t\t\tMeCP2 dysfunction in Rett syndrome and related disorders.\n\t\t\t\t\tCurrent Opinion in Genetics & Development,\n\t\t\t\t\t16(3),\n\t\t\t\t\t276\u2013\n\t\t\t\t\t281.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.gde.2006.04.009","DOI":"10.1016\/j.gde.2006.04.009"},{"key":"2020111911300275500_i1944-7558-125-6-493-Mount1","doi-asserted-by":"crossref","unstructured":"Mount,\n              R. H.,\n            \n            \n              Charman,\n              T.,\n            \n            \n              Hastings,\n              R. P.,\n            \n            \n              Reilly,\n              S.,\n             &\n\t\t\t\t\t\tCass,H.\n          (2002).\n\t\t\t\t\tThe Rett Syndrome Behaviour Questionnaire (RSBQ): Refining the behavioural phenotype of Rett syndrome.\n\t\t\t\t\tJournal of Child Psychology and Psychiatry,\n\t\t\t\t\t43(8),\n\t\t\t\t\t1099\u2013\n\t\t\t\t\t1110.\n\t\t\t\t\thttps:\/\/doi.org\/10.1111\/1469-7610.00236","DOI":"10.1111\/1469-7610.00236"},{"key":"2020111911300275500_i1944-7558-125-6-493-Muthen1","unstructured":"Muth\u00e9n,\n              L. K.\n             and\n\t\t\t\t\t\tMuth\u00e9n,B. O.\n          (1998\u20132017\n          ).\n\t\t\t\t\tMplus user's guide (8th ed.).\n\t\t\t\t\tMuth\u00e9n & Muth\u00e9n."},{"key":"2020111911300275500_i1944-7558-125-6-493-Neul1","doi-asserted-by":"crossref","unstructured":"Neul,\n              J. L.,\n            \n            \n              Fang,\n              P.,\n            \n            \n              Barrish,\n              J.,\n            \n            \n              Lane,\n              J.,\n            \n            \n              Caeg,\n              E. B.,\n            \n            \n              Smith,\n              E. O.,\n            \n            \n              Zoghbi,\n              H.,\n            \n            \n              Percy,\n              A.\n             &\n\t\t\t\t\t\tGlaze,D. G.\n          (2008).\n\t\t\t\t\tSpecific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome.\n\t\t\t\t\tNeurology,\n\t\t\t\t\t70(16),\n\t\t\t\t\t1313\u2013\n\t\t\t\t\t1321.\n\t\t\t\t\thttps:\/\/doi.org\/10.1212\/01.wnl.0000291011.54508.aa","DOI":"10.1212\/01.wnl.0000291011.54508.aa"},{"key":"2020111911300275500_i1944-7558-125-6-493-Neul2","doi-asserted-by":"crossref","unstructured":"Neul,\n              J. L.,\n            \n            \n              Glaze,\n              D. G.,\n            \n            \n              Percy,\n              A. K.,\n            \n            \n              Feyma,\n              T.,\n            \n            \n              Beisang,\n              A.,\n            \n            \n              Dinh,\n              T.,\n            \n            \n              Suter,\n              B.,\n            \n            \n              Anagnostou,\n              E.,\n            \n            \n              Snape,\n              M.,\n            \n            \n              Horrigan,\n              J.\n             &\n\t\t\t\t\t\tJones,N. E.\n          (2015).\n\t\t\t\t\tImproving treatment trial outcomes for Rett syndrome: The development of Rett-specific anchors for the Clinical Global Impression Scale.\n\t\t\t\t\tJournal of Child Neurology,\n\t\t\t\t\t30(13),\n\t\t\t\t\t1743\u2013\n\t\t\t\t\t1748.\n\t\t\t\t\thttps:\/\/doi.org\/10.1177\/0883073815579707","DOI":"10.1177\/0883073815579707"},{"key":"2020111911300275500_i1944-7558-125-6-493-Neul3","doi-asserted-by":"crossref","unstructured":"Neul,\n              J. L.,\n            \n            \n              Kaufmann,\n              W. E.,\n            \n            \n              Glaze,\n              D. G.,\n            \n            \n              Christodoulou,\n              J.,\n            \n            \n              Clarke,\n              A. J.,\n            \n            \n              Bahi-Buisson,\n              N.,\n            \n            \n              Leonard,\n              H.,\n            \n            \n              Bailey,\n              M. E. S.,\n            \n            \n              Schanen,\n              N. C.,\n            \n            \n              Zappella,\n              M.,\n            \n            \n              Renieri,\n              A.,\n            \n            \n              Huppke,\n              P.,\n             &\n\t\t\t\t\t\tPercy,A. K.\n          (2010).\n\t\t\t\t\tRett syndrome: Revised diagnostic criteria and nomenclature.\n\t\t\t\t\tAnnals of Neurology,\n\t\t\t\t\t68(6),\n\t\t\t\t\t944\u2013\n\t\t\t\t\t950.\n\t\t\t\t\thttps:\/\/doi.org\/10.1002\/ana.22124","DOI":"10.1002\/ana.22124"},{"key":"2020111911300275500_i1944-7558-125-6-493-Neul4","doi-asserted-by":"crossref","unstructured":"Neul,\n              J. L.,\n            \n            \n              Lane,\n              J. B.,\n            \n            \n              Lee,\n              H.-S.,\n            \n            \n              Geerts,\n              S.,\n            \n            \n              Barrish,\n              J. O.,\n            \n            \n              Annese,\n              F.,\n            \n            \n              Baggett,\n              L. M.,\n            \n            \n              Barnes,\n              K.,\n            \n            \n              Skinner,\n              S. A.,\n            \n            \n              Motil,\n              K. J.,\n            \n            \n              Glaze,\n              D. J.,\n            \n            \n              Kaufmann,\n              W. E.,\n             &\n\t\t\t\t\t\tPercy,A. K.\n          (2014).\n\t\t\t\t\tDevelopmental delay in Rett syndrome: Data from the natural history study.\n\t\t\t\t\tJournal of Neurodevelopmental Disorders,\n\t\t\t\t\t6(1),\n\t\t\t\t\t20.\n\t\t\t\t\thttps:\/\/doi.org\/10.1186\/1866-1955-6-20","DOI":"10.1186\/1866-1955-6-20"},{"key":"2020111911300275500_i1944-7558-125-6-493-Patrick1","doi-asserted-by":"crossref","unstructured":"Patrick,\n              D. L.,\n            \n            \n              Burke,\n              L. B.,\n            \n            \n              Gwaltney,\n              C. J.,\n            \n            \n              Leidy,\n              N. K.,\n            \n            \n              Martin,\n              M. L.,\n            \n            \n              Molsen,\n              E.,\n             &\n\t\t\t\t\t\tRing,L.\n          (2011).\n\t\t\t\t\tContent validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: Part 2\u2014assessing respondent understanding.\n\t\t\t\t\tValue in Health,\n\t\t\t\t\t14(8),\n\t\t\t\t\t978\u2013\n\t\t\t\t\t988.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.jval.2011.06.013","DOI":"10.1016\/j.jval.2011.06.013"},{"key":"2020111911300275500_i1944-7558-125-6-493-Powers1","doi-asserted-by":"crossref","unstructured":"Powers,\n              J. H.,\n            \n            \n              Patrick,\n              D. L.,\n            \n            \n              Walton,\n              M. K.,\n            \n            \n              Marquis,\n              P.,\n            \n            \n              Cano,\n              S.,\n            \n            \n              Hobart,\n              J.,\n            \n            \n              Isaac,\n              M.,\n            \n            \n              Vamvakas,\n              S.\n            \n            \n              Slagle,\n              A.,\n            \n            \n              Molsen,\n              E.,\n             &\n\t\t\t\t\t\tBurke,L. B.\n          (2017).\n\t\t\t\t\tClinician-reported outcome assessments of treatment benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force.\n\t\t\t\t\tValue in Health,\n\t\t\t\t\t20(1),\n\t\t\t\t\t2\u2013\n\t\t\t\t\t14.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.jval.2016.11.005","DOI":"10.1016\/j.jval.2016.11.005"},{"key":"2020111911300275500_i1944-7558-125-6-493-Sansone1","doi-asserted-by":"crossref","unstructured":"Sansone,\n              S. M.,\n            \n            \n              Schneider,\n              A.,\n            \n            \n              Bickel,\n              E.,\n            \n            \n              Berry-Kravis,\n              E.,\n            \n            \n              Prescott,\n              C.,\n             &\n\t\t\t\t\t\tHessl,D.\n          (2014).\n\t\t\t\t\tImproving IQ measurement in intellectual disabilities using true deviation from population norms.\n\t\t\t\t\tJournal of Neurodevelopmental Disorders,\n\t\t\t\t\t6(1),\n\t\t\t\t\t16.\n\t\t\t\t\thttps:\/\/doi.org\/10.1186\/1866-1955-6-16","DOI":"10.1186\/1866-1955-6-16"},{"key":"2020111911300275500_i1944-7558-125-6-493-SASInstituteInc1","unstructured":"SAS Institute, Inc.\n          (2012-2017\n          ). SAS version 9.4 [Computer software].\n\t\t\t\t\tCary, NC:\n\t\t\t\t\tSAS Institute, Inc."},{"key":"2020111911300275500_i1944-7558-125-6-493-Schreiber1","doi-asserted-by":"crossref","unstructured":"Schreiber,\n              J. B.,\n            \n            \n              Nora,\n              A.,\n            \n            \n              Stage,\n              F. K.,\n            \n            \n              Barlow,\n              E. A.,\n             &\n\t\t\t\t\t\tKing,J.\n          (2006).\n\t\t\t\t\tReporting structural equation modeling and confirmatory factor analysis results: A review.\n\t\t\t\t\tThe Journal of Educational Research,\n\t\t\t\t\t99(6),\n\t\t\t\t\t323\u2013\n\t\t\t\t\t338.\n\t\t\t\t\thttps:\/\/doi.org\/10.3200\/JOER.99.6.323-338","DOI":"10.3200\/JOER.99.6.323-338"},{"key":"2020111911300275500_i1944-7558-125-6-493-Schultz1","unstructured":"Schultz,\n              R. J.,\n             &\n\t\t\t\t\t\tGlaze,C. D. G.\n          (2017).\n\t\t\t\t\tRett syndrome: Genetics, clinical features, and diagnosis.\n\t\t\t\t\tUpToDate.\n\t\t\t\t\thttps:\/\/www.uptodate.com\/contents\/rett-syndrome-genetics-clinical-features-and-diagnosis"},{"key":"2020111911300275500_i1944-7558-125-6-493-Schwartzman1","doi-asserted-by":"crossref","unstructured":"Schwartzman,\n              J. S.,\n            \n            \n              Velloso,\n              R. D. L.,\n            \n            \n              D'Antino,\n              M. E. F.,\n             &\n\t\t\t\t\t\tSantos,S.\n          (2015).\n\t\t\t\t\tThe eye-tracking of social stimuli in patients with Rett syndrome and autism spectrum disorders: A pilot study.\n\t\t\t\t\tArquivos de Neuro-Psiquiatria,\n\t\t\t\t\t73(5),\n\t\t\t\t\t402\u2013\n\t\t\t\t\t407.\n\t\t\t\t\thttps:\/\/doi.org\/10.1590\/0004-282X20150033","DOI":"10.1590\/0004-282X20150033"},{"key":"2020111911300275500_i1944-7558-125-6-493-Slade1","doi-asserted-by":"crossref","unstructured":"Slade,\n              A.,\n            \n            \n              Isa,\n              F.,\n            \n            \n              Kyte,\n              D.,\n            \n            \n              Pankhurst,\n              T.,\n            \n            \n              Kerecuk,\n              L.,\n            \n            \n              Ferguson,\n              J.,\n            \n            \n              Lipkin,\n              G.,\n             &\n\t\t\t\t\t\tCalvert,M.\n          (2018).\n\t\t\t\t\tPatient reported outcome measures in rare diseases: A narrative review.\n\t\t\t\t\tOrphanet Journal of Rare Diseases,\n\t\t\t\t\t13(1),\n\t\t\t\t\t61.\n\t\t\t\t\thttps:\/\/doi.org\/10.1186\/s13023-018-0810-x","DOI":"10.1186\/s13023-018-0810-x"},{"key":"2020111911300275500_i1944-7558-125-6-493-USDHHSFDA1","unstructured":"U. S. Department of Health and Human Services, Food and Drug Administration.\n          \n            Guidance for industry: Patient-reported outcomes measures: Use in medical product development to support labeling claims.\n\t\t\t\t\tDecember2009.\n\t\t\t\t\thttp:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf"},{"key":"2020111911300275500_i1944-7558-125-6-493-Walton1","doi-asserted-by":"crossref","unstructured":"Walton,\n              M. K.,\n            \n            \n              Powers,\n              J. H.,\n            \n            \n              Hobart,\n              J.,\n            \n            \n              Patrick,\n              D.,\n            \n            \n              Marquis,\n              P.,\n            \n            \n              Vamvakas,\n              S.,\n            \n            \n              Isaac,\n              M.,\n            \n            \n              Molsen,\n              E.,\n            \n            \n              Cano,\n              S.,\n             &\n\t\t\t\t\t\tBurke,L. B.\n          (2015).\n\t\t\t\t\tClinical outcome assessments: conceptual foundation\u2014Report of the ISPOR clinical outcomes assessment\u2013emerging good practices for outcomes research task force.\n\t\t\t\t\tValue in Health,\n\t\t\t\t\t18(6),\n\t\t\t\t\t741\u2013\n\t\t\t\t\t752.\n\t\t\t\t\thttps:\/\/doi.org\/10.1016\/j.jval.2015.08.006","DOI":"10.1016\/j.jval.2015.08.006"},{"key":"2020111911300275500_i1944-7558-125-6-493-Wang1","doi-asserted-by":"crossref","unstructured":"Wang,\n              H.,\n            \n            \n              Pati,\n              S.,\n            \n            \n              Pozzo-Miller,\n              L.,\n             &\n\t\t\t\t\t\tDoering,L. C.\n          (2015).\n\t\t\t\t\tTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.\n\t\t\t\t\tFrontiers in Cellular Neuroscience,\n\t\t\t\t\t9,\n\t\t\t\t\t55.\n\t\t\t\t\thttps:\/\/doi.org\/10.3389\/fncel.2015.00055","DOI":"10.3389\/fncel.2015.00055"}],"container-title":["American Journal on Intellectual and Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/ajidd\/article-pdf\/125\/6\/493\/2651162\/i1944-7558-125-6-493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/ajidd\/article-pdf\/125\/6\/493\/2651162\/i1944-7558-125-6-493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:34:46Z","timestamp":1768322086000},"score":1,"resource":{"primary":{"URL":"https:\/\/meridian.allenpress.com\/ajidd\/article\/125\/6\/493\/448180\/A-Psychometric-Evaluation-of-the-Motor-Behavioral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,19]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1352\/1944-7558-125.6.493","relation":{},"ISSN":["1944-7558","1944-7515"],"issn-type":[{"value":"1944-7558","type":"electronic"},{"value":"1944-7515","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}